In particular, the decreased expression of SOCS2 significantly associated with advanced pathological stage, lymph node metastasis and shorter overall survival in lung adenocarcinoma patients. This evidence concerns the gene SOCS2 and metastatic malignant neoplasm in the lymph nodes.